Spinal Morphine in Robotic Assisted Radical Prostatectomy

Phase 3

Completed

• Conditions: Postoperative pain after prostatectomy; woundpain; 10025506

• Registration Number: NL-OMON43716
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 160

Inclusion Criteria

Adults (>18 years), scheduled for RARP

Exclusion Criteria

Age under 18 years old, Renal Insufficiency (MRDR <30 ml/min), Contra-indications for spinal anaesthesia (severe Aortic Valve stenosis, coagulation disorders, increased intracranial pressure), conversion to an open procedure, post-operative ICU-admission, allergies to studymedication.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>QoR-15-scale at day 1 and day 7-10.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secundary goals are to decrease the use of systemic opiates (in mg of morfine).<br /><br>Less bladderspasms and pain (both on a NRS-scale (0-10)<br /><br>Reduce the side-effects op opiates (nausea, vomiting, pruritus, sedation (NRS<br /><br>0-10)<br /><br>Increase the patient-satisfaction (NRS 0-10), mobility (NRS 0-10) and surgical<br /><br>workspace (NRS 0-10).</p><br>